Membrane Actions of Vitamin D Metabolites 1α,25(OH)2D 3 and 24R,25(OH)2D3 Are Retained in Growth Plate Cartilage Cells from Vitamin D Receptor Knockout Mice

Journal of Cellular Biochemistry

Volumn 90, Issue 6, 2003, Pages 1207-1223

  Boyan, Barbara D ^a,b   Sylvia, V L ^b   McKinney, N ^b   Schwartz, Z ^a,b,c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

1 ,25(OH)2D3; 24R,25(OH)2D3; Growth plate chondrocytes; Membrane receptors; Rapid actions of steroid hormones; VDR knockout mice; Vitamin D metabolites

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; BINDING PROTEIN; CALCITRIOL; CHELERYTHRINE; MEMBRANE RECEPTOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEOGLYCAN; STEROID HORMONE; SULFUR 35; TRITIUM; VITAMIN D; VITAMIN D RECEPTOR;

ALOPECIA; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH PLATE; HORMONAL REGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEINASE INHIBITION; PROTEOGLYCAN SYNTHESIS; RICKETS; SIGNAL TRANSDUCTION; SULFATION; VITAMIN D METABOLISM; WILD TYPE;

24,25-DIHYDROXYVITAMIN D 3; ANIMALS; CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; CHONDROCYTES; DISEASE MODELS, ANIMAL; GROWTH PLATE; MICE; MICE, KNOCKOUT; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOLIPASES A; PROTEIN KINASE C; PROTEOGLYCANS; RATS; RECEPTORS, CALCITRIOL; RICKETS; SIGNAL TRANSDUCTION; SULFATES; VITAMIN D;

EID: 0344011652     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10716     Document Type: Article

References (59)

1. Amizuka N, Kwan MY, Goltzman D, Ozawa H, White JH. 1999. Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage. J Clin Invest 103:373-381.
2. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analysis. Endocrinology 140:4982-4987.
3. Arcaro A, Wymann MP. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 296:297-301.
4. Asada S, Fukuda K, Nishisaka F, Matsukawa M, Hamanisi C. 2001. Hydrogen peroxide induces apoptosis of chondrocytes; involvement of calcium ion and extracellular signal-regulated protein kinase. Inflamm Res 50:19-23.
5. Baran DT, Quail JM, Ray R, Honeyman T. 2000a. Binding of 1alpha, 25-dihydroxyvitamin D(3) to annexin II: Effect of vitamin D metabolites and calcium. J Cell Biochem 80:259-265.
6. Baran DT, Quail JM, Ray R, Leszyk J, Honeyman T. 2000b. Annexin II is the membrane receptor that mediates the rapid actions of 1α ,25-dihydroxyvitamin D3. J Cell Biochem 78:34-46.
7. Bleasdale J, Bundy GL, Bunting S, Fitzpatrick FA, Huff RM, Sun FF, Pike JE. 1989. Inhibition of phospholipase C-dependent processes by U73,122. Adv Prostaglandin Thromboxane Leukot Res 19:590-593.
8. Boyan BD, Schwartz Z, Carnes DL, Jr., Ramirez V. 1988a. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology 122:2851-2860.
9. Boyan BD, Schwartz Z, Swain LD, Carnes DL, Jr., Zislis T. 1988b. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro. Bone 9:185-194.
10. Boyan BD, Swain LD, Schwartz Z, Ramirez V, Carnes DL, Jr. 1992. Epithelial cell lines which induce bone formation in vivo produce alkaline phosphatase-enriched matrix vesicles in culture. Clin Orthop Rel Res 277:266-276.
11. Boyan BD, Dean DD, Sylvia VL, Schwartz Z. 1997a. Cartilage and vitamin D: Genomic and nongenomic regulation by 1,25-(OH)2D3 and 24,25-(OH)2D3. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego, CA: Academic Press. pp 395-421.
12. Boyan BD, Posner GH, Greising DM, White MC, Sylvia VL, Dean DD, Schwartz Z. 1997b. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway. J Cell Biochem 66:457-470.
13. Boyan BD, Sylvia VL, Dean DD, Schwartz Z. 1997c. Effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on protein kinase C in chondrocytes are mediated by phospholipase A2 and arachidonic acid. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: Chemistry, biology, and clinical applications of the steroid hormone. Riverside, California: University of California at Riverside. pp 353-360.
14. Boyan BD, Sylvia VL, Dean DD, Pedrozo H, Del Toro F, Nemere I, Posner GH, Schwartz Z. 1999. 1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2. Steroids 64:129-136.
15. Boyan BD, Bonewald LF, Sylvia VL, Nemere I, Larsson D, Norman AW, Rosser J, Dean DD, Schwartz Z. 2002a. Evidence for distinct membrane receptors for 1α,25-(OH)2D3 and 24R,25-(OH)2D3 in osteoblasts. Steroids 67:235-246.
16. Boyan BD, Sylvia VL, Dean DD, Del Toro F, Schwartz Z. 2002b. Differential regulation of growth plate chondrocytes by 1α,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell maturation specific membrane receptor activated phospholipid metabolism. Crit Rev Oral Biol Med 13:143-154.
17. Cancela L, Nemere I, Norman AW. 1988. 1 alpha,25(OH)2 vitamin D3: A steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms (Review). J Steroid Biochem 30:33-39.
18. Chen CH, Sakai Y, Demay MB. 2001. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology 142:5386-5389.
19. Church D, Braconi S, Vallotton M, Lang U. 1993. Protein kinase C-mediated phospholipase A2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes. Biochem J 290:477-482.
20. de Boland AR, Norman AW. 1990. Evidence for involvement of protein kinase C and cyclic adenosine 3′,5′ monophosphate-dependent protein kinase in the 1, 25-dihydroxy-vitamin D3-mediated rapid stimulation of intestinal calcium transport, (transcaltachia). Endocrinology 127:39-45.
21. de Boland AR, Norman AW. 1998. 1α,25-(OH)2D3-vitamin D3 signaling in chick enterocytes: Enhancement of tyrosine phosphorylation and rapid stimulation of mitogen-activated protein (MAP) kinase. J Cell Biochem 69:470-482.
22. de Boland AR, Morelli S, Boland R. 1994. 1,25(OH)2-vitamin D3 signal transduction in chick myoblasts involves phosphatidylcholine hydrolysis. J Biol Chem 269:8675-8679.
23. de Boland AR, Facchinetti MM, Balogh G, Massheimer V, Boland RL. 1996. Age-associated decrease in inositol 1,4,5-trisphosphate and diacylglycerol generation by 1,25(OH)2-vitamin D3 in rat intestine. Cell Signal 8:153-157.
24. Donohue MM, Demay MB. 2002. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 143:3691-3694.
25. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Moller G, Adamski J, Balling R. 2002. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16:1524-1537.
26. Farach-Carson MC, Ridall AL. 1998. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: Cross-talk between genomic and membrane-initiated pathways. Am J Kidney Dis 31:729-742.
27. Greising DM, Schwartz Z, Posner GH, Sylvia VL, Dean DD, Boyan BD. 1997. A-ring analogues of 1,25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation. J Cell Physiol 171:357-367.
28. Helm SH, Sylvia VL, Harmon T, Dean DD, Boyan BD, Schwartz Z. 1996. 24,25-(OH)2D3 regulates protein kinase C through two distinct phospholipid-dependent mechanisms. J Cell Physiol 169:509-521.
29. Herbert JM, Augereau JM, Gleye J, Maffrand JP. 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993-999.
30. Kato A, Seo E-G, Einhorn TA, Bishop JE, Norman AW. 1998. Studies on 24R,25-dihydroxyvitamin D3: Evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus. Bone 23:141-146.
31. Kim YS, MacDonald PN, Dedhar S, Hruska KA. 1996. Association of 1α,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites. Endocrinology 137:3649-3658.
32. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835.
33. Lin R, Amizuka N, Sasaki T, Aarts MM, Ozawa H, Goltzman D, Henderson JE, White JH. 2002. 1Alpha,25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J Bone Miner Res 17:1604-1612.
34. Mesbah M, Nemere I, Papagerakis P, Nefussi JR, Orestes-Cardoso S, Nessmann C, Berdal A. 2002. Expression of a 1,25-dihydroxyvitamin D3 membrane-associated rapid-response steroid binding protein during human tooth development and biomineralization. J Bone Miner Res 17:1588-1596.
35. Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T, Yamada K, Yoshida M, Kase H, Matsuda Y. 1992. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem 267:2157-2163.
36. Nasatzky E, Schwartz Z, Boyan BD, Soskolne WA, Ornoy A. 1993. Sex-dependent effects of 17-β-estradiol on chondrocyte differentiation in culture. J Cell Physiol 154:359-367.
37. Nemere I, Norman AW. 1988. 1,25-Dihydroxyvitamin D3-mediated vesicular transport of calcium in intestine: Time-course studies. Endocrinology 122:2962-2969.
38. Nemere I, Schwartz Z, Pedrozo H, Sylvia VL, Dean DD, Boyan BD. 1998. Identification of a membrane receptor for 1,25-dihydroxy vitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res 13:1353-1359.
39. Nemere I, Larsson D, Sundell K. 2000. A specific binding moiety for 1,25-dihydroxyvitamin D3 in basal lateral membranes of carp enterocytes. Am J Physiol Endocrinol Metab 279:E614-E621.
40. Nemere I, Safford SE, DeSouza MM, Farach-Carson MC. 2001. Characterization of 1,25D3-membrane-associated rapid response, steroid binding (1,25D3-MARRS) protein from the domestic chicken (Abst., 41st Ann Mtg, Am Soc Cell Biol). Mole Biol Cell 12(Suppl):331A.
41. Nemere I, Yazzie-Atkinson D, Johns DO, Larsson D. 2003. Biochemical characterization and purification of a binding protein for 24,25-dihydroxyvitamin D3 from chick intestine. J Endocrinol 172:211-219.
42. Norman AW. 2000. 1α,25(OH)2D3-mediated rapid and genomic responses in human leukemic NB4 cells: Evidence for involvement of crosstalk from rapid responses to genomic effects. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D endocrine system. Riverside, CA: University of California, Riverside. pp 691-698.
43. O'Keefe RJ, Puzas JE, Brand JS, Rosier RN. 1988. Effects of transforming growth factor-beta on matrix synthesis by chick growth plate chondrocytes. Endocrinology 122:2953-2961.
44. Pedrozo HA, Schwartz Z, Rimes S, Sylvia VL, Nemere I, Posner GH, Dean DD, Boyan BD. 1999. Physiological importance of the 1,25-(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25-(OH)2D3. J Bone Miner Res 14:856-867.
45. Schwartz Z, Schlader DL, Swain LD, Boyan BD. 1988. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities. Endocrinology 123:2878-2884.
46. Schwartz Z, Schlader DL, Ramirez V, Kennedy MB, Boyan BD. 1989. Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro. J Bone Miner Res 4:199-207.
47. Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD. 1995. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes. Endocrinology 136:402-411.
48. Schwartz Z, Sylvia VL, Larsson D, Nemere I, Casasola D, Dean DD, Boyan BD. 2001a. 1α,25(OH)2D3 regulates chondrocyte matrix vesicle protein kinase C directly via G-protein dependent mechanisms and indirectly via incorporation of PKC during matrix vesicle biogenesis. J Biol Chem 5:11828-11837.
49. Schwartz Z, Sylvia VL, Luna MH, DeVeau P, Whetstone R, Dean DD, Boyan BD. 2001b. The effect of 24R,25-(OH)2D3 on protein kinase C activity in chondrocytes is mediated by phospholipase D whereas the effect of 1α,25-(OH)2D3 is mediated by phospholipase C. Steroids 66:683-694.
50. Schwartz Z, Ehland H, Sylvia VL, Larsson D, Bingham V, Hardin RR, Lopez D, Dean DD, Boyan BD. 2002. 1α,25(OH)2D3 and 24R,25(OH)2D3 modulate growth plate chondrocyte physiology via PKC-dependent phosphorylation of ERK1/2 MAP kinase. Endocrinology 143:2775-2786.
51. Schwartz Z, Shaked D, Hardin RR, Gruwell S, Dean DD, Sylvia VL, Boyan BD. 2003. 1α,25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-β activity via phospholipase A2 dependent production of lysophospholipid. Steroids (in press).
52. Seo EG, Einhorn TA, Norman AW. 1996. 24R-25dihydroxyvitamin D3: An essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. J Bone Miner Res 11:S422.
53. Somjen D, Somjen GJ, Harell A, Mechanic GL, Binderman I. 1982. Partial characterization of a specific high affinity binding macromolecule for 24,25-dihydroxyvitamin D3 in differentiating skeletal mesenchyme. Biochem Biophys Res Commun 106:644-651.
54. Sylvia VL, Schwartz Z, Schuman L, Morgan RT, Mackey S, Gomez R, Boyan BD. 1993. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures. J Cell Physiol 157:271-278.
55. Sylvia VL, Schwartz Z, Ellis EB, Dean DD, Boyan BD. 1994. The nongenomic effect of 1,25-(OH)2D3 on growth zone chondrocytes is mediated by protein kinase C (abstract). FASEB J 8:A1236.
56. Sylvia VL, Schwartz Z, Holmes SC, Dean DD, Boyan BD. 1997. 24,25-(OH)2D3 regulation of matrix vesicle protein kinase C occurs both during biosynthesis and in the extracellular matrix. Calcif Tissue Int 61:313-321.
57. Sylvia VL, Schwartz Z, Curry DB, Chang Z, Dean DD, Boyan BD. 1998. 1,25-(OH)2D3 regulates protein kinase C activity through two phospholipid-independent pathways involving phospholipase A2 and phospholipase C in growth zone chondrocytes. J Bone Miner Res 13:559-569.
58. Sylvia VL, Schwartz Z, Del Toro F, DeVeau P, Whetstone R, Hardin RR, Dean DD, Boyan BD. 2001. Regulation of phospholipase D (PLD) in growth plate chondrocytes by 24R,25(OH)2D3 is dependent on cell maturation state (resting zone cells) and is specific to the PLD2 isoform. Biochim Biophys Acta 1499:209-221.
59. Xu L, Tan L, Goldring MB, Olsen BR, Li Y. 2001. Expression of frizzled genes in mouse costochondral chondrocytes. Matrix Biol 20:147-151.